Sanjaymon KR, General Manager - Business Development, Agappe
Automation industry in clinical chemistry is growing faster in India. With advancement in technologies, the entry level automation segment is moving ahead with a faster pace. With advancement in the IT, most of the new generation systems are equipped with reagent and sample barcodes having HIS/LIS connectivity. By integrating the systems to the HIS/LIS interface, the analytical errors are reduced drastically.
One of the new trends is remote diagnosis where the hardware is connected to the cloud based server and is checked for errors periodically. This new initiative from the hardware manufacturers is one of the key reasons for the minimal down time. Integration is playing an important role in IVD and the manufacturers are moving towards integrated systems to give complete solution to the customers. Usage of smart card based technology is another trend in the industry. Now more systems are coming up with smart card based calibration/programming where the cost of calibration is eluded.
From conventional systems with turn around table for samples, new generation systems are coming up with rack sampling technology for ease of use. These systems allow the customer continuous loading of sample without any interruption of the process and thus helps to reduce the TAT of testing. Fluidics mechanisms and photometry modules are evolving to a new era with the ability to handle very low volume liquids. There is a huge reduction in the reagent volume requirement and now there are systems which can perform the tests with 80uL reagent, reducing the cost of testing drastically.
The advancements in the robotic mechanisms made it possible to have compact systems with higher throughput. Latex enhanced immunoturbidimetry based testing is becoming popular in the industry because of the specificity, sensitivity, and accuracy. These parameters are easily adaptable to the new generation clinical chemistry platforms and witnessed an exponential growth over the last three years. It is expected that more parameters are going to be introduced in the LEIT platform which can be performed in the clinical chemistry systems to make the diagnosis easy and affordable.